FIRST TRACKS BIOTHERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
FIRST TRACKS BIOTHERAPEUTICS, INC. (TRAX) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $146.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-12
- FIRST TRACKS BIOTHERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $146.00K.
- FIRST TRACKS BIOTHERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$122.00K.
- FIRST TRACKS BIOTHERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was -$167.00K.
- FIRST TRACKS BIOTHERAPEUTICS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-03-31 was -$144.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month |
|---|---|---|
| 2026-06-30 | $146.00K 10-Q · filed 2026-08-12 | $24.00K derived: sum of 2 quarters · filed 2026-08-12 |
| 2026-03-31 | -$122.00K 10-Q · filed 2026-08-12 | |
| 2025-06-30 | -$167.00K 10-Q · filed 2026-08-12 | -$311.00K derived: sum of 2 quarters · filed 2026-08-12 |
| 2025-03-31 | -$144.00K 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |